Biothera Competitors and Similar CompaniesClear all

Biothera's competitors and similar companies include Akebia Therapeutics, AKESOgen and Novartis Gene Therapies.
Biothera
Biothera
Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems.
Akebia Therapeutics
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
AKESOgen
AKESOgen
AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural
Novartis Gene Therapies
Novartis Gene Therapies
Novartis Gene Therapies (formerly known as AveXis) is a biotech company developing innovative treatments for rare and life-threatening genetic diseases.
Founding Date
Founding Date
1997
Founding Date
2007
Founding Date
2010
Founding Date
2010
Type
Type
Private
Type
Public
Type
Subsidiary
Type
Subsidiary
Tags
Locations
Locations
Roseville, US HQ
Locations
Cambridge, US HQ
Locations
Norcross, US HQ
Locations
Bannockburn, US HQ
Employees
Employees
542% increase
Employees
324187% increase
Employees
6
Employees
6603% decrease

Financial

Net income
Net income
N/A
Net income
($5.3m) (FY, 2025)
Net income
N/A
Net income
($218.1m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 5.1m
Total funding raised
N/A
Total funding raised
$ 1.5m
Total funding raised
$ 75m
For sources of this data, please see the company profile

View Company Profiles

Akebia Therapeutics
HQ
Cambridge, US
Employees
324

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

View company
AKESOgen
HQ
Norcross, US

AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural

View company
Novartis Gene Therapies
HQ
Bannockburn, US

Novartis Gene Therapies (formerly known as AveXis) is a biotech company developing innovative treatments for rare and life-threatening genetic diseases.

View company